No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|24|8|865-874

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.8, 2015-08, pp. : 865-874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Metformin and Survival of Diabetic Women with Breast Cancer

By  

Current Drug Safety, Vol. 8, Iss. 5, 2013-11 ,pp. : 357-363

Bentham Science Publishers

Access to resources Recommend Favorite

Dietary intake of isoflavones and coumestrol and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 4, 2018-02 ,pp. : 719-728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Smoking and survival of colorectal cancer patients: Population‐based study from Germany

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1433-1445

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment

By  

Urologia Internationalis, Vol. 98, Iss. 1, 2016-09 ,pp. : 79-84

Karger

Access to resources Recommend Favorite

Clopidogrel use and cancer‐specific mortality: a population‐based cohort study of colorectal, breast and prostate cancer patients

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 8, 2015-08 ,pp. : 830-840

John Wiley & Sons Inc

Access to resources Recommend Favorite